Symphogen
Signe Schønemann Hansen has worked as an Accountant at Symphogen since March 2022. Prior to that, they worked at Scandinavian Tobacco Group from December 2015 to March 2022, first as a Regnskabsassistent from February 2016, and then as a Bogholder (vikar via Powerpeople) from December 2015 to January 2016. Signe also worked at Radiometer as an Økonomiassistent from May 2014 to April 2015, and at DELTA as a Regnskabsassistent from March 2009 to April 2014, following their role as an Administrativ elev from March 2007 to March 2009.
Signe Schønemann Hansen attended Lyngby Uddannelsescenter from 2005 to 2007, where they completed a HG degree. The specific field of study during their time at Lyngby Uddannelsescenter is unknown.
This person is not in any offices
Symphogen
3 followers
Symphogen is a clinical-stage antibody oncology focused company with a differentiated product pipeline and significant commercial opportunities. Inspired by nature, led by science and driven by people, we passionately strive to make that discovery that may have great effect on the lives of patients, their families, and their caregivers. Based on our monoclonal antibody (mAb) research platform, we create differentiated mAb and mAb mixture products candidates. Our pre-clinical and clinical pipeline is well suited for a precision-medicine approach by addressing well-defined, biomarker-selected patient populations. We are headquartered in Denmark with operations in the US.